Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P54803: Variant p.Arg396Trp

Galactocerebrosidase
Gene: GALC
Feedback?
Variant information Variant position: help 396 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Arginine (R) to Tryptophan (W) at position 396 (R396W, p.Arg396Trp). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from large size and basic (R) to large size and aromatic (W) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -3 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In KRB. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 396 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 685 The length of the canonical sequence.
Location on the sequence: help GLGNLTIIIETMSHKHSKCI R PFLPYFNVSQQFATFVLKGS The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         GLGNLTIIIETMSHKHSKCIR-PFLPYFNVSQQFATFVLKGS

                              GLGNLTIIVETMSHKQSACIR-PFLPYFNVSRQFATFVLKG

Rhesus macaque                GLGNLTIIIETMSHKHSKCIR-PFLPYFNVSQQFATFVLKG

Mouse                         GLGNLTIIIETMSHQHSMCIR-PYLPYYNVSHQLATFTLKG

Xenopus laevis                RLGNLTVIIETMSHNNSICIR-PPLPEYNVSAQNATFYLQG

Xenopus tropicalis            RLGNLTIVIETMSHNNSICIR-PPLPDYNVSAQYATFYLQG

Zebrafish                     RKGNLTIIIETMTHEHSQCIR-PPLPHFDVSPQIATFELKG

Caenorhabditis elegans        GKDS-TIFVETMSYKKSLCEYSSPRPYHVKPSQLIRF----
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 43 – 685 Galactocerebrosidase
Binding site 396 – 396
Glycosylation 379 – 379 N-linked (GlcNAc...) asparagine
Glycosylation 403 – 403 N-linked (GlcNAc...) asparagine



Literature citations
Molecular genetics of Krabbe disease (globoid cell leukodystrophy): diagnostic and clinical implications.
Wenger D.A.; Rafi M.A.; Luzi P.;
Hum. Mutat. 10:268-279(1997)
Cited for: VARIANTS KRB ASP-111; ALA-194; THR-263; THR-295; PHE-303; TRP-396; LEU-400; SER-468; SER-514; MET-529; CYS-531; SER-567; SER-592 AND ARG-645; Advances in the Diagnosis and Treatment of Krabbe Disease.
Wenger D.A.; Luzi P.; Rafi M.A.;
Int. J. Neonatal Screen. 7:0-0(2021)
Cited for: VARIANTS KRB ASP-111; ALA-112; ASP-286; PHE-303; TRP-396; MET-529; SER-567 AND SER-634;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.